Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for Parkinson's disease.

Shin-Ichi Muramatsu

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |December 20, 2018
    PubMed
    Summary

    Gene therapy offers three promising strategies for Parkinson's disease, focusing on dopamine restoration, neuroprotection, and neural activity modulation. Clinical studies show these gene therapy approaches are safe and beneficial for motor symptoms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AAV-based gene therapy with modified HEXB confers lasting therapeutic benefits in GM2 gangliosidosis models.

    Cell reports. Medicine·2026
    Same author

    An Analysis of Biomarkers for the Evaluation of Gene Therapy in Niemann-Pick Disease Type C1 Mice.

    Human gene therapy·2026
    Same author

    Correction: Machine learning model for predicting the cold-heat pattern in Kampo medicine: a multicenter prospective observational study.

    Frontiers in pharmacology·2026
    Same author

    Less Invasive Light Irradiation Methods for Inner Ear Gene Therapy Based on Photoswitch Technology: Toward Clinical Translation.

    Human gene therapy·2026
    Same author

    Teneurin-4 in the nucleus accumbens modulates affective-like behaviors with potential effects on astrocytes in male mice.

    Biochemical and biophysical research communications·2026
    Same author

    Spinal Shati/nat8l regulates mechanical hyperalgesia through NAAG-mGluR3 signaling in neuropathic pain.

    Neuropharmacology·2026

    Area of Science:

    • Neuroscience
    • Genetics
    • Neurology

    Background:

    • Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons.
    • Current treatments primarily manage symptoms but do not halt disease progression.
    • Gene therapy presents novel therapeutic avenues for Parkinson's disease.

    Purpose of the Study:

    • To review and summarize the current gene therapy strategies for Parkinson's disease.
    • To evaluate the safety and efficacy of these gene therapy approaches.
    • To highlight the potential of gene therapy as a neuroprotective and restorative treatment.

    Main Methods:

    • Gene transfer of dopamine-synthesizing enzymes to restore dopamine production in the putamen.
    • Gene delivery of neurotrophic factors to protect nigrostriatal projections.
    • Modulation of subthalamic nucleus activity via gene delivery of inhibitory neurotransmitter synthesis enzymes.

    Main Results:

    • All investigated gene therapy procedures were well-tolerated by patients.
    • No adverse effects were attributed to the viral vectors used in the studies.
    • Beneficial effects on motor symptoms were observed, particularly with putaminal gene transfer, and confirmed in children with AADC deficiency.

    Conclusions:

    • Gene therapy offers a safe and potentially effective treatment modality for Parkinson's disease.
    • Restorative and neuroprotective strategies show promise in improving motor function.
    • Early intervention is crucial for neuroprotective gene therapy strategies to maximize benefits before significant neurodegeneration occurs.

    Related Experiment Videos